The Head and Neck Oncology Program at OSUCCC–James is at the forefront of the world’s efforts to improve outcomes of patients with head and neck malignancies. The program’s multidisciplinary team of experts – including medical oncologists, surgical oncologists, radiation oncologists, plastic surgeons and researchers – collaborate to improve the detection, treatment and rehabilitation of head and neck cancers. Their bench to bedside focus means patients are consistently offered newer, safer and more effective treatments as they are developed.
Groundbreaking research which has resulted in improved outcomes and treatment advancements include:
- Leading breakthroughs in the association between HPV and head and neck cancers, which is changing the way clinical trials are designed, with investigators stratifying patients by HPV status
- Improving cure rates for nasopharyngeal cancer
- Developing novel treatment approaches for anterior skull base tumors and advanced stage resectable mouth and throat cancers
- Developing new reconstructive surgical approaches for the throat, voice box and windpipe
- Using microarray technology to generate a tumor-specific gene expression profile for squamous cell carcinoma of the head and neck, identifying gene-specific causative and prognostic biomarkers for the disease.
The Head and Neck Oncology Program is located on the first floor of The James Cancer Hospital and Solove Research Institute, located at 300 W. 10th Ave., Columbus, Ohio 43210. For more information about our services, please contact us at (614) 293-8074.
Learn about clinical trials, ongoing research and our team of head and neck experts at the links below.
How to Refer